Clinical trial
Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial
NCT02258984 is registered in ClinicalTrials.gov with Mespere Lifesciences Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial
- Lead sponsor
- Mespere Lifesciences Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2014
- Completion date
- December 31, 2015
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute heart failure, severe sepsis